FR EN

Back


26/06/2017
Life Sciences company M2i receives €12m in funding from Idinvest Partners
Idinvest Partners today announced €12 million in funding for life sciences company M2i as part of the firm's continued support of high-growth European SMEs. The funds raised will enable biocontrol producer M2i to finance the approval process of its Biocontrol products, pursue its R&D investment strategy and accelerate its international development. Matthieu Baret, Partner at Idinvest, commented: "This investment comes from the Idinvest Growth Fund II which targets small-mid cap companies that have the potential to expand globally and become industry leaders within the Digital, Health and Smart Cities sectors." 

Download the pdf file





X

X

X